Adults with MASLD had reduced serum and liver miR‐155 content compared to a control group, while liver transcripts for SREBP1 and fatty acid synthase were increased [29]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.